Science 37 to Present at the 5ᵗʰ Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Science 37 Holdings, Inc. (Nasdaq: SNCE) announced participation in the 5th Annual Evercore ISI HealthCONx Conference. The event includes a virtual fireside chat scheduled for December 1, 2022, at 8:50 a.m. Eastern Time. Interested parties can access the live and archived webcast through the company’s website. Science 37 is recognized for pioneering decentralized clinical trials, aiming to enhance access to clinical research. With its innovative technology platform, the company enables faster enrollment and improved retention in clinical studies.

RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Science 37^® Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming 5^th Annual Evercore ISI HealthCONx Conference.

Science 37’s management is scheduled to participate virtually in a fireside chat on Thursday, December 1, 2022, at 8:50 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investor Relations” section of the company’s website at: https://investors.science37.com.

About Science 37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable universal access to clinical research—making it easier for patients and providers to participate from anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized clinical trials, the Science 37 l Operating System (OS) supports today’s more agile clinical research designs with its full stack, end-to-end technology platform and centralized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, provider communities, and data and devices. Configurable to enable almost any study type, the Science 37 OS enables up to 21x faster enrollment, 28% better retention and 3x more diverse patient population with industry-leading workflow orchestration, evidence generation and data harmonization. For more information, visit https://www.science37.com.

MEDIA INQUIRIES:
Grazia Mohren Science 37
Email: pr@science37.com

INVESTOR RELATIONS:
Steven Halper
LifeSci Advisors
Investors@science37.com

FAQ

What is the date and time of Science 37's participation in the Evercore ISI HealthCONx Conference?

Science 37 will participate in the conference on December 1, 2022, at 8:50 a.m. Eastern Time.

How can I access the webcast of Science 37's fireside chat?

The webcast can be accessed live and archived on Science 37's Investor Relations website.

What does Science 37 specialize in?

Science 37 specializes in decentralized clinical trials, facilitating universal access to clinical research.

What are some benefits of Science 37's technology platform?

The platform allows for up to 21x faster enrollment, 28% better retention, and a 3x more diverse patient population.

Where is Science 37 Holdings, Inc. located?

Science 37 Holdings, Inc. is based in Research Triangle Park, North Carolina.